Source: Eur Respir Mon; 2004: 28: 131–145
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
G.C. Schito, A. Marchese. The impact of antibiotic resistance in the management of lower respiratory tract infections. Eur Respir Mon; 2004: 28: 131–145

Member's Comments

No comment yet.

Related content which might interest you: Antibiotic resistance of Streptococcus pneumoniae and Haemophilus influenzae strains isolated from community-aquired inferior respiratory tract infections in Romania Source: Eur Respir J 2001; 18: Suppl. 33, 140s Year: 2001 Bacteriological evidence of antibiotic failure in pneumococcal lower respiratory tract infections Source: Eur Respir J 2002; 20: 3S-8S Year: 2002 Resistance of respiratory tract Streptococcus pneumoniae strains Source: Eur Respir J 2002; 20: Suppl. 38, 358s Year: 2002 Penicillin resistance rates for streptococcus pneumoniae strains isolated from lower respiratory tract infections Source: Eur Respir J 2002; 20: Suppl. 38, 358s Year: 2002 Streptococcus pneumoniae resistance pattern and its clinical implications Source: Annual Congress 2006 - PG1 - Respiratory infections: pneumonia/antibiotic resistance and clinical outcome of lower respiratory tract infections Year: 2006 Future antibiotics and current practices for treating respiratory tract infections Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=255 Year: 2004 Community-acquired pneumonia in Europe: causative pathogens and resistance patterns Source: Eur Respir J 2002; 20: 20S-27S Year: 2002 Macrolides, quinolones and amoxicillin/clavulanate for chronic bronchitis: a meta-analysis Source: Eur Respir J 2007; 29: 1127-1137 Year: 2007 Study of the prevalence of Moraxella (Branhamella) catarrhalis in the patients suffering from lower respiratory tract infection Source: Eur Respir J 2005; 26: Suppl. 49, 144s Year: 2005 Levofloxacin non-susceptible streptococcus pneumoniae in community-acquired respiratory infection; prevalence and risk factors Source: Annual Congress 2007 - Antibiotic treatment in community-acquired pneumonia Year: 2007 Azithromycin treatment failure in macrolide-resistant Mycoplasma pneumoniae pneumonia Source: Eur Respir J 2010; 36: 969-971 Year: 2010 Antibiotic susceptibility testing on streptococcus pneumoniae strains obtained from respiratory tract specimens Source: Eur Respir J 2001; 18: Suppl. 33, 139s Year: 2001 Impact of initial antibiotic choice on mortality from pneumococcal pneumonia Source: Eur Respir J 2006; 27: 1010-1019 Year: 2006 Peculiarities of community-acquired pneumonia course, caused by multiresistant strains of S. pneumoniae Source: Eur Respir J 2006; 28: Suppl. 50, 165s Year: 2006 Antibiotic resistance genotype trend and association with host clinical characteristics in respiratory isolates of streptococcus pneumoniae Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options Year: 2014 Haemophilus influenzae in COPD patients with poorer lung function carry more antibiotic resistance Source: Eur Respir J 2002; 20: Suppl. 38, 544s Year: 2002 Streptococcus pneumoniae is the main causative agent of community-acquired pneumonia Source: Eur Respir J 2002; 20: Suppl. 38, 608s Year: 2002 Analysis of hospital acquired infection of low respiratory tract by Klebsiella pneumoniael and Escherichia coli and antibiotic resistance Source: Eur Respir J 2003; 22: Suppl. 45, 149s Year: 2003 S. pneumoniae community-acquired pneumonia (SP-CAP): relationship between mortality and antibiotic susceptibility and risk factors for drug resistance Source: Eur Respir J 2001; 18: Suppl. 33, 503s Year: 2001 Comparison of azithromycin versus clarithromycin in the treatment of patients with lower respiratory tract infection in which Streptococcus pyogenes was isolated in sputum culture Source: Eur Respir J 2004; 24: Suppl. 48, 414s Year: 2004